Prof. Bidyut Roy

Indian Statistical Institute, India

Email: bidyutroy8933@gmail.com

Qualifications

1994   Postdoctoral Fellow, Institute of Molecular and Cellular Biology and Genetics, molecular biology

1991   Research Scientist and Fellow, Research Institute for Radiation Biology and Medicine, cancer biology

Publications (Selected)

1. N. Sikdar, R. R. Paul and B. Roy. Glutathione S-transferase M3 (A/A) genotype as a risk factor for oral cancer and leukoplakia among Indian tobacco smokers. Int. J. Cancer, 109, 95-101, 2004.
2. S. Mitra, N. Sikdar, C. Misra, S. Gupta, R. R. Paul, B. Roy, C. K. Panda and S. Roychoudhury. Risk assessment of p53 genotypes and haplotypes in tobacco associated leukoplakia and oral cancer patients from eastern India. Int. J. Cancer, 117, 786-793, 2005.
3. M. Majumder, N. Sikdar, R. R. Paul and B. Roy. Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes, one on each of GSTM3 and XRCC1 (codon 280). Cancer Epidemiol Biomark Preven, 14, 2106-12, 2005.
4. B. Roy, S. K. Ghosh, D. Sutradhar, N. Sikdar, S. Mazumder and S. Barman. Predisposition of anti-tuberculosis drug induced hepatotoxicity by cytochrome P450 2E1 genotype and haplotype in pediatric patients. J. Gastroenterol. Hepatol, 21, 784-86, 2006. 
5. M. Majumder, N. Sikdar, S. Ghosh and B. Roy. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int. J. Cancer 120, 2148-56, 2007.
6. S. Datta, M. Majumder; N. K. Biswas N. Sikdar and B. Roy. Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and autosomal GSTP1 locus. Cancer, 110, 1991-1999, 2007.
7. P. Das Roy, M. Majumder and B. Roy. Pharmacogenomics of anti-TB drugs related hepatotoxicity. Pharmacogenomics, 9, 311-21, 2008.
8. Ghosh S, Ghosh A, Maiti G P, Alam, N, Roy A, Roy B, Roychoudhury S and Panda C K. Alterations of 3p21.31 tumor suppressor genes in head and neck squamous cell carcinoma: correlation with progression and prognosis. Int J Cancer, 123, 2594-2604, 2008.
9. M. Majumder, D. Indra, P. Das Roy, S. Datta, J. G. Ray, C. K. Panda and B. Roy. Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples. J Oral Pathol Med, 38, 174-180, 2009.
10. Ghosh A, Ghosh S, Maiti GP, Sabbir MG, Alam N, Sikdar N, Roy B, Roychoudhury S and Panda C. SH3GL2 and CDKN2A/2B loci are independently altered in early dysplastic lesion of head and neck cancer: correlation with HPV infection and tobacco habit. J Pathol, 217, 408-19, 2009.
11. Misra C, Majumder M, Bajaj S, Ghosh S, Roy B and Roychoudhury S. Polymorphisms at p53, p73 and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol Carcinogenesis, 48, 790-800, 2009.
12. Majumder M, Ghosh S and Roy B: Association between polymorphisms at NAT1 and risk of oral leukoplakia and cancer. Ind. J. Med Res, 136(4), 605-13, 2012.
13. De Sarkar N., Majumder M, Roy B: Differential haplotype amplification leads to misgenotyping of heterozygote to homozygote when using single nucleotide mismatch primers. Eletrophoresis, 33(23), 3564-73, 2012.
14. Das Roy P, Sengupta D, Dasgupta AK, Kundu S, Chaudhuri U, Thakur  I, Guha P, Majumder M, Roy R, Roy B: Single Nucleotide Polymorphism Network- a combinatorial paradigm for risk prediction. Plos One, 8(9), e74067, 2013.
15. Mondal P, Datta S, Maiti GP, Baral A, Jha GN, Panda CK, Chowdhury S, Ghosh S, Roy B, Roychoudhury S : Comprehensive SNP scan of DNA repair and DNA damage response genes reveal multiple susceptibility loci conferring risk to tobacco associated leukoplakia and oral cancer., PLoS One, 8(2):e56952 doi: 10.1371/journal.pone.0056952, (2013).
16. Roy R, De Sarkar N, Ghose S, Paul RR, Pal M, Bhattacharya C, Chowdhury SK, Ghosh S, Roy B: Genetic variations at microRNA and processing genes and risk of oral cancer, Tumour Biology, 2014, 35, 3409-14, Doi 10.1007/S13277-013-1450-3.
17. Roy R, De Sarkar N, Ghose S, Paul RR, Ray A, Mukhopadhyay I, Roy B. Association between risk of oral precancer and genetic variations in microRNA and related processing genes. J. Biomed. Science, 2014.21:48.
18. De Sarkar N, Roy R, Mitra JK, Sandip Ghose S, Chakraborty A, Paul RR, Mukhopadhyay I, Roy B. A quest for miRNA bio-marker: A track back approach from gingivo buccal cancer to two different types of precancers. Plos One , Aug 15, 9(8), e104839, 2014.
19. Datta S, Chattopadhyay E, Ray JG, Majumder M, Das Roy P and Roy B. D-loop somatic mutations and ~5kb “common” deletion in mitochondrial DNA: Important molecular markers to distinguish oral precancer and cancer.  Tumor Biology, 20 Dec, 2014.
20. Maiti GP, Ghosh A, Mondal P, Baral A, Datta S, Samadder S, Nayak SP, Chakraborty J, Biswas J, Sikdar N, Choudhury S, Roy B, Roychowdhury S, Panda C. The SNP rs1049430 in the 3’UTR of SH3GL2 regulates its expression: clinical and prognostic implication in head and neck cancer squamous cell carcinoma. BBA: 1852, 1059-67, 2015.
21. Ray A, Paul S, Chattopadhyay E, Kundu S, Roy B: Genetic analysis of familial spontaneous pneumothorax in an Indian Family. Lung, 193, 433-38. 2015.